Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04799990
Status:
WITHDRAWN
Last Update Posted:
2022-12-09
First Post:
2021-03-15
Brief Title:
Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-15
First Submit QC Date:
March 15 2021
Study First Post Date:
2021-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-08
Last Update Post Date:
2022-12-09
Last Update Post Date Type:
ACTUAL